Latest Market Pricing News

Donaco International shareholders have overwhelmingly approved a scheme of arrangement for On Nut Road Limited to acquire the company at a significant premium, setting the stage for a major ownership change pending court approval.

Veris Limited has announced the renewal of its on-market share buy-back program, aiming to repurchase up to 10% of its shares over the next year. This move reflects confidence in its financial position and current market conditions.

Clime Capital Limited (ASX, CAM) has announced a $14 million convertible note offer featuring a 6.5% fixed interest rate and a maturity date in 2028. The notes are convertible into ordinary shares on a one-for-one basis, providing investors with a hybrid income and equity exposure.

Aura Energy has locked in a landmark long-term uranium offtake agreement with a major US nuclear utility alongside a flexible spot sales deal, marking a pivotal step toward commercialising its Tiris Uranium Project in Mauritania.

BirdDog Technology Limited offers shareholders a voluntary off-market buy-back at 7 cents per share, a significant premium to recent trading prices, as it prepares for delisting from the ASX.

Duxton Water Limited has significantly reduced its debt and maintained steady dividends while navigating a challenging water market marked by dry conditions and rising lease yields.

Ovanti Limited has appointed Peter Maher, a seasoned BNPL executive from Zip Co, to lead its US expansion, while exploring a NASDAQ listing via dual-listing or SPAC merger and reconsidering the sale of a key dividend-yielding asset.

GWR Group Limited reports steady progress on its Prospect Ridge magnesium project with ongoing metallurgical testing and a strong cash position of $38 million. The company also revises Wiluna iron ore royalty terms and pursues strategic acquisitions.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

Energy Metals Limited reported steady progress in its uranium exploration projects during the June 2025 quarter, supported by a strong cash position and rising uranium prices. Preparations to refresh the Bigrlyi Pre-Feasibility Study and regional exploration groundwork highlight the company’s strategic focus.

Astron Corporation has cleared major regulatory hurdles for its Donald Rare Earth and Mineral Sands Project, releasing a robust updated economic study that underscores the project's long-term value and advancing financing discussions.

Lotus Resources is on track to restart uranium production at its Kayelekera project in Malawi by Q3 2025, backed by binding offtake contracts covering nearly 4 million pounds of uranium and a robust cash position.